Skip to content
Disclosery

13F-HR filed by ACUTA CAPITAL PARTNERS, LLC

ACUTA CAPITAL PARTNERS, LLC filed this 13F-HR for the quarter ended 2024-09-30, filed 2024-11-14, with 41 holding rows worth $123,463,831.

Accession
0001104659-24-118283
Filer
CIK 1582844
Filed
2024-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2024

A holdings report, 41 entries on the cover page, a total value of $123,463,831 stated on the cover page (in dollars after the unit check, H1), rows summing to $123,463,831 with VALUE read as dollars as filed, 13F file number 028-16527. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
VAXCYTE INC COM92243G108Stock135,400$15,472,158dollars as filed
OCULAR THERAPEUTIX INC67576A100COM1,190,071$10,353,618dollars as filed
Tourmaline Bio Inc89157D105Common Stock332,095$8,538,162dollars as filed
INSMED INC COM PAR $.01457669307Stock107,500$7,847,500dollars as filed
ENLIVEN THERAPEUTICS INC COM29337E102Stock296,368$7,569,239dollars as filed
CRINETICS PHARMACEUTICALS INC COM22663K107Stock131,700$6,729,870dollars as filed
ARCELLX INC COMMON STOCK03940C100Stock62,100$5,185,971dollars as filed
MEREO BIOPHARMA GROUP PLC589492107CMN1,260,700$5,181,477dollars as filed
REVOLUTION MEDICINES INC COM76155X100Stock108,000$4,897,800dollars as filed
TAYSHA GENE THERAPIES INC877619106COMMON STOCK2,118,992$4,259,174dollars as filed
TERNS PHARMACEUTICALS INC COM880881107Stock487,000$4,061,580dollars as filed
KURA ONCOLOGY INC COM50127T109Stock197,000$3,849,380dollars as filed
WHITEHAWK THERAPEUTICS INC00032Q104CMN1,849,402$3,809,768dollars as filed
ROCKET PHARMACEUTICALS INC77313F106COM190,000$3,509,300dollars as filed
PRAXIS PRECISION MEDICINES I74006W207COM NEW57,500$3,308,550dollars as filed
ARGENX SE SPONSORED ADR04016X101ADR5,900$3,198,272dollars as filed
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR21,000$3,135,510dollars as filed
COMPASS PATHWAYS PLC20451W101SPONSORED ADS386,500$2,434,950dollars as filed
Mersana Therapeutics Inc59045L106Common Stock1,200,000$2,268,000dollars as filed
HELIX ACQUISITION CORP IIG4444H101CL A ORD SHS180,945$1,890,857dollars as filed
ACELYRIN INC00445A100COM364,000$1,794,520dollars as filed
EDGEWISE THERAPEUTICS INC28036F105COM63,000$1,681,470dollars as filed
DYNE THERAPEUTICS INC COM26818M108Stock46,200$1,659,504dollars as filed
Gilead Sciences,Inc.375558103COM19,500$1,634,880dollars as filed
ULTRAGENYX PHARMACEUTICAL IN90400D108COM25,100$1,394,305dollars as filed
TREVI THERAPEUTICS INC COM89532M101Stock290,500$970,270dollars as filed
UNICYCIVE THERAPEUTICS INC90466Y103CMN1,979,199$807,315dollars as filed
LIQUIDIA CORPORATION COM NEW53635D202Stock73,500$735,000dollars as filed
VERVE THERAPEUTICS INC92539P101COM146,100$707,124dollars as filed
GERON CORP374163103COM154,900$703,246dollars as filed
CELCUITY INC15102K100COM46,600$694,806dollars as filed
ARTIVA BIOTHERAPEUTICS INC04317A107COM44,000$679,800dollars as filed
TECTONIC THERAPEUTIC INC878972108COMMON STOCK13,700$415,110dollars as filed
CORBUS PHARMACEUTICALS21833P301COM NEW18,500$381,655dollars as filed
RAPPORT THERAPEUTICS INC COM75383L102Stock17,600$360,448dollars as filed
CYPHERPUNK TECHNOLOGIES INC52187K200COM NEW120,500$309,685dollars as filed
CLIMB BIO INC28658R106COMMON STOCK54,000$274,860dollars as filed
BENITEC BIOPHARMA INC08205P209COMMON STOCK29,800$273,862dollars as filed
TRAVERE THERAPEUTICS INC89422G107COM19,000$265,810dollars as filed
THIRD HARMONIC BIO INC88427A107COM15,508$210,133dollars as filed
NUVATION BIO INC67080N119WARR90,832$8,892dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-24-118283this filing2024-11-14acceptance time not in the bulk data set